Possible Clinical Benefits of Cardio-Ankle Vascular Index Measurement in Urological Diseases

References

• Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation. 2000;7(2):83–101. doi:10.1038/sj.mn.7300096
   PubMed Web of Science ®Google Scholar
• Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of the cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord. 2011;11(1):1–10. doi:10.1186/1471-2261-11-51
   PubMedGoogle Scholar
• Lee MH, Perl DP, Nair G, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med. 2021;384(5):481–483. doi:10.1056/NEJMc2033369
   PubMed Web of Science ®Google Scholar
• Gonzalez‐Juanatey C, Llorca J, Miranda‐Filloy JA, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Care Res. 2007;57(2):287–293. doi:10.1002/art.22530
   Web of Science ®Google Scholar
• Sari I, Okan T, Akar S, et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology. 2006;45(3):283–286. doi:10.1093/rheumatology/kei145
   PubMed Web of Science ®Google Scholar
• Gandaglia G, Briganti A, Jackson G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014;65(5):968–978. doi:10.1016/j.eururo.2013.08.023
   PubMed Web of Science ®Google Scholar
• Salonia A, Minhas S, Bettocchi C, et al. EAU guidelines. End. Presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5; Arnhem, The Netherlands: EAU Guidelines Office; 2022.
   Google Scholar
• Kilinc MF, Yasar E, Aydin HI, Yildiz Y, Doluoglu OG. Association between coronary artery disease severity and overactive bladder in geriatric patients. World J Urol. 2018;36(1):35–40. doi:10.1007/s00345-017-2098-1
   PubMed Web of Science ®Google Scholar
• Andersson KE, De Groat WC, McVary KT, et al. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism (s) of action. Neurourol Urodyn. 2011;30(3):292–301. doi:10.1002/nau.20999
   PubMed Web of Science ®Google Scholar
• Haga N, Akaihata H, Hata J, et al. The association between local atherosclerosis of the prostatic artery and benign prostatic enlargement in humans: putative mechanism of chronic ischemia for prostatic enlargement. Prostate. 2018;1–12. doi:10.1002/pros.23658
   Web of Science ®Google Scholar
• Yeniel AO, Ergenoglu AM, Meseri R, et al. Is overactive bladder microvasculature disease a component of systemic atherosclerosis? Neurourol Urodyn. 2017;1–8. doi:10.1002/nau.23452
   Web of Science ®Google Scholar
• Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl. 2003;24(S6):S17–S37. doi:10.1002/j.1939-4640.2003.tb02743.x
   PubMedGoogle Scholar
• Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB. Overactivity and structural changes in the chronically ischemic bladder. J Urol. 1999;162(5):1768–1778. doi:10.1016/S0022-5347(05)68236-5
   PubMed Web of Science ®Google Scholar
• Inci M, Sarli B, Davarci M, et al. Relationship between endothelial dysfunction and nocturia with benign prostatic hyperplasia. Scand J Urol. 2013;47(5):384–389. doi:10.3109/21681805.2012.762038
   PubMed Web of Science ®Google Scholar
• Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86(2):207–210. doi:10.1016/S0002-9149(00)00857-2
   PubMed Web of Science ®Google Scholar
• McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin ND, Wilkinson IB. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension. 2006;48(4):602–608. doi:10.1161/01.HYP.0000239206.64270.5f
   PubMed Web of Science ®Google Scholar
• Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circulation J. 2007;72(4):598–604. doi:10.1253/circj.72.598
   Web of Science ®Google Scholar
• Halcox JP, Donald AE, Ellins E, et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation. 2009;119(7):1005–1012. doi:10.1161/CIRCULATIONAHA.108.765701
   PubMed Web of Science ®Google Scholar
• Willum Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113(5):664–670. doi:10.1161/CIRCULATIONAHA.105.579342
   PubMed Web of Science ®Google Scholar
• Aydın E, Kant A, Yilmaz G. Evaluation of the cardio-ankle vascular index in COVID-19 patients. Revista da Associação Médica Brasileira. 2021;68:73–76. doi:10.1590/1806-9282.20210781
   Web of Science ®Google Scholar
• Maloberti A, Vallerio P, Triglione N, et al. Vascular aging and disease of the large vessels: role of inflammation. High Blood Pressure Cardiovasc Prev. 2019;26:175–182. doi:10.1007/s40292-019-00318-4
   PubMed Web of Science ®Google Scholar
• Nagayama D, Sugiura T, Choi SY, Shirai K. Various obesity indices and arterial function evaluated with CAVI–is waist circumference adequate to define metabolic syndrome? Vasc Health Risk Manag. 2022;721–733. doi:10.2147/VHRM.S378288
   PubMed Web of Science ®Google Scholar
• Hayashi K, Handa H, Nagasawa S, Okumura A, Moritake K. Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech. 1980;13(2):175–184. doi:10.1016/0021-9290(80)90191-8
   PubMed Web of Science ®Google Scholar
• Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111(25):3384–3390. doi:10.1161/CIRCULATIONAHA.104.483628
   PubMed Web of Science ®Google Scholar
• Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101–107. doi:10.5551/jat.13.101
   PubMed Web of Science ®Google Scholar
• Chang ST, Chu CM, Hsu JT, et al. Scrutiny of cardiovascular risk factors by assessing arterial stiffness in erectile dysfunction patients. World J Urol. 2010;28(5):625–630. doi:10.1007/s00345-009-0486-x
   PubMed Web of Science ®Google Scholar
• Imai A, Yamamoto H, Hatakeyama S, et al. Risk factors for erectile dysfunction in healthy Japanese men. Int J Androl. 2010;33(4):569–573. doi:10.1111/j.1365-2605.2009.00974.x
   PubMedGoogle Scholar
• Demirelli E, Karagöz A, Öğreden E, et al. The relationship between the severity of erectile dysfunction and aortic stiffness. Andrologia. 2020;52:e13544. doi:10.1111/and.13544
   PubMed Web of Science ®Google Scholar
• Solomon H, Wierzbicki AS, Lumb PJ, Lambert-Hammill M, Jackson G. Cardiovascular risk factors determine erectile and arterial function response to sildenafil. Am J Hypertens. 2006;19(9):915–919. doi:10.1016/j.amjhyper.2006.02.010
   PubMed Web of Science ®Google Scholar
• Shigemura K, Arakawa S, Kamidono S, Nakano Y, Fujisawa M. Effect of sildenafil on arterial stiffness, as assessed by pulse wave velocity, in patients with erectile dysfunction. Int J Urol. 2006;13(7):956–959. doi:10.1111/j.1442-2042.2006.01447.x
   PubMed Web of Science ®Google Scholar
• Bulbul E, Aydin E, Yilmaz E. Evaluation of endothelial dysfunction with cardio-ankle vascular index measurements in patients with erectile dysfunction. Andrology. 2022;10:926–930. doi:10.1111/andr.13191
   PubMed Web of Science ®Google Scholar
• Motil I, Kubis I, Sramkova T. Treatment of vasculogenic erectile dysfunction with Piezowave2 device. Application of low-intensity shockwaves using novel linear shockwave tissue coverage (LSTC-ED®) technique. A prospective, multicentric, placebo-controlled study. Adv Sex Med. 2016;6(02):15. doi:10.4236/asm.2016.62002
   Google Scholar
• Yamaguchi O, Nomiya M, Andersson KE. Functional consequences of chronic bladder ischemia. Neurourol Urodyn. 2014;33(1):54–58. doi:10.1002/nau.22517
   PubMed Web of Science ®Google Scholar
• Tikkinen KA, Auvinen A, Johnson TM, et al. A systematic evaluation of factors associated with nocturia: the population-based FINNO Study. Am J Epidemiol. 2009;170:361–368. doi:10.1093/aje/kwp133
   PubMed Web of Science ®Google Scholar
• Uzun H, Çiçek Y, Kocaman SA, Durakoğlugil ME, Zorba OÜ. Increased pulse-wave velocity and carotid intima–media thickness in patients with lower urinary tract symptoms. Scand J Urol. 2013;47(5):393–398. doi:10.3109/21681805.2013.780185
   PubMed Web of Science ®Google Scholar
• Yabe M, Haga N, Ogawa S, et al. Atherosclerosis as a predictor of delayed recovery from lower urinary tract dysfunction after robot‐assisted laparoscopic radical prostatectomy. Neurourol Urodyn. 2016;35(8):920–925. doi:10.1002/nau.22824
   PubMed Web of Science ®Google Scholar
• Shirai K, Song M, Suzuki J, et al. Contradictory effects of β1-and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)—CAVI is independent of blood pressure. J Atheroscler Thromb. 2011;18(1):49–55. doi:10.5551/jat.3582
   PubMed Web of Science ®Google Scholar
• Shimizu A, Sakakibara R, Takahashi O, Tateno F, Aiba Y. Bladder overactivity and post-void residual: which relates more to systemic atherosclerotic markers? Autonom Neurosci. 2020;223:102600. doi:10.1016/j.autneu.2019.102600
   PubMed Web of Science ®Google Scholar
• Koguchi T, Haga N, Matsuoka K, et al. Atherosclerosis as a predictor of transient exacerbation of overactive bladder symptoms after robot‐assisted laparoscopic radical prostatectomy. Int J Urol. 2019;26(2):234–240. doi:10.1111/iju.13848
   PubMed Web of Science ®Google Scholar
• Hsiao SM, Tu FC, Su TC, Wu PC, Lin HH. Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial. Sci Rep. 2022;12(1):1–8. doi:10.1038/s41598-022-18391-6
   PubMed Web of Science ®Google Scholar
• Hsiao SM, Su TC, Chen CH, Chang TC, Lin HH. Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects. Maturitas. 2014;79(1):65–69. doi:10.1016/j.maturitas.2014.06.001
   PubMed Web of Science ®Google Scholar
• Jiang Y, Fan F, Jia J, et al. Brachial–ankle pulse wave velocity is independently associated with urine albumin-to-creatinine ratio in a Chinese community-based cohort. Int Urol Nephrol. 2020;52(4):713–720. doi:10.1007/s11255-020-02404-2
   PubMed Web of Science ®Google Scholar
• Latif W, Karaboyas A, Tong L, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470–2477. doi:10.2215/CJN.00670111
   PubMed Web of Science ®Google Scholar
• Harada M, Fujii K, Yamada Y, et al. Relationship between serum uric acid level and vascular injury markers in hemodialysis patients. Int Urol Nephrol. 2020;52(8):1581–1591. doi:10.1007/s11255-020-02531-w
   PubMed Web of Science ®Google Scholar
• Nagayama D, Fujishiro K, Miyoshi T, et al. Predictive ability of arterial stiffness parameters for renal function decline: a retrospective cohort study comparing cardio-ankle vascular index, pulse wave velocity and cardio-ankle vascular index0. J Hypertens. 2022;40(7):1294–1302. doi:10.1097/HJH.0000000000003137
   PubMed Web of Science ®Google Scholar
• Sahinkus S, Aydin E, Aksoy MNM, Akcay C, Eynel E, Yaylaci S. Association between cardio-ankle vascular index and contrast-induced nephropathy. Hypertension. 2020;27(3.3):0–993.
   Google Scholar
• Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000;35:S117–S131. doi:10.1016/S0272-6386(00)70239-3
   PubMed Web of Science ®Google Scholar
• Amann K, Tyralla K. Cardiovascular changes in chronic renal failure--pathogenesis and therapy. Clin Nephrol. 2002;58:S62–72.
   PubMed Web of Science ®Google Scholar
• Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439. doi:10.1161/01.CIR.99.18.2434
   PubMed Web of Science ®Google Scholar
• Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005;45(3):494–501. doi:10.1053/j.ajkd.2004.11.011
   PubMed Web of Science ®Google Scholar
• Ishimura T, Endo T, Nishioka S, et al. MP59-19 Anti-atherosclerotic effect of everolimus in kidney-transplanted patients. J Urol. 2020;203(Supplement 4):e888–e888.
   PubMedGoogle Scholar